Daiken Medical Co., Ltd. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020
November 01, 2019 at 11:30 am IST
Share
Daiken Medical Co., Ltd. announced non-consolidated earnings results for the six months ended September 30, 2019. For the six months, the company reported net sales of ¥4,248 million against ¥4,195 million a year ago. Operating profit was ¥565 million against ¥705 million a year ago. Ordinary profit of ¥579 million against ¥703 million a year ago. Profit was ¥414 million or ¥14.42 per share against ¥485 million or ¥16.26 per share a year ago.
For the year, the company expects net sales of ¥8,500 million, operating profit of ¥1,280 million, ordinary profit of ¥1,300 million and profit of ¥870 million or ¥30.28 per share.
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.
Daiken Medical Co., Ltd. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020